Late-onset neutropenia after rituximab in ANCA-associated vasculitis.
about
Effect of FCGR polymorphism on the occurrence of late-onset neutropenia and flare-free survival in rheumatic patients treated with rituximab.Avoidance of Harm From Treatment for ANCA-Associated Vasculitis.Antineutrophil cytoplasmic antibody associated vasculitides with renal involvement: Open challenges in the remission induction therapy.
P2860
Late-onset neutropenia after rituximab in ANCA-associated vasculitis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Late-onset neutropenia after rituximab in ANCA-associated vasculitis.
@en
Late-onset neutropenia after rituximab in ANCA-associated vasculitis.
@nl
type
label
Late-onset neutropenia after rituximab in ANCA-associated vasculitis.
@en
Late-onset neutropenia after rituximab in ANCA-associated vasculitis.
@nl
prefLabel
Late-onset neutropenia after rituximab in ANCA-associated vasculitis.
@en
Late-onset neutropenia after rituximab in ANCA-associated vasculitis.
@nl
P2093
P2860
P1476
Late-onset neutropenia after rituximab in ANCA-associated vasculitis.
@en
P2093
A Bruchfeld
I Gunnarsson
O Börjesson
V Malmström
Y Sundström
P2860
P304
P356
10.3109/03009742.2016.1138318
P577
2016-03-07T00:00:00Z